Literature DB >> 27859807

Putative tissue location and function of the SLC5 family member SGLT3.

Matúš Soták1, Joanne Marks2, Robert J Unwin1,2,3,4.   

Abstract

NEW
FINDINGS: What is the topic of this review? This review summarizes the evidence on the localization, electrophysiological properties, agonist specificity and putative physiological role of sodium-glucose transporter 3 (SGLT3). What advances does it highlight? Published information is reviewed in some detail by comparing human and rodent isoforms, as well as advances in testing hypotheses for the physiological role of SGLT3 as a glucose sensor or incretin release mediator. We provide a critical overview of available published data and discuss a putative functional role for SGLT3 in human and mouse physiology. Sodium-glucose transporter 3 (SGLT3) has attracted interest because of its putative role as a glucose sensor, rather than a sugar transporter, in contrast to its co-family members SGLT1 and SGLT2. Significant progress has been made in characterizing the electrophysiological properties in vitro of the single human SGLT3 isoform and the two mouse isoforms, SGLT3a and SGLT3b. Although early reports indicated SGLT3 expression in the small intestinal myenteric and submucosal neurones, hypothalamic neurones, portal vein and kidney, a lack of reliable antibodies has left unanswered its exact tissue and cellular localization. Several hypotheses for a role of SGLT3 in glucose sensing, gastric emptying, glucagon-like peptide-1 release and post-Roux-en-Y gastric bypass remodelling have been explored, but so far there is only limited and indirect supportive evidence using non-specific agonists/antagonists, with no firm conclusions. There are no published or available data in knockout animals, and translation is difficult because of its different isoforms in human versus rodent, as well as a lack of selective agonists or antagonists, all of which make SGLT3 challenging to study. However, its unique electrophysiological properties, ubiquitous expression at the mRNA level, enrichment in the small intestine and potential, but uncertain, physiological role demand more attention. The purpose of this overview and review of SGLT3 biology is to provide an update, highlight the gaps in our knowledge and try to signpost potential ways forward to define its likely function in vivo.
© 2017 The Authors. Experimental Physiology © 2017 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27859807     DOI: 10.1113/EP086042

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  12 in total

Review 1.  Emerging Concepts in Brain Glucose Metabolic Functions: From Glucose Sensing to How the Sweet Taste of Glucose Regulates Its Own Metabolism in Astrocytes and Neurons.

Authors:  Menizibeya O Welcome; Nikos E Mastorakis
Journal:  Neuromolecular Med       Date:  2018-07-18       Impact factor: 3.843

Review 2.  The neural basis of sugar preference.

Authors:  Winston W Liu; Diego V Bohórquez
Journal:  Nat Rev Neurosci       Date:  2022-07-25       Impact factor: 38.755

Review 3.  Glucose transporters in the kidney in health and disease.

Authors:  Volker Vallon
Journal:  Pflugers Arch       Date:  2020-03-06       Impact factor: 3.657

Review 4.  Novel and Unexpected Functions of SGLTs.

Authors:  Ernest M Wright; Chiara Ghezzi; Donald D F Loo
Journal:  Physiology (Bethesda)       Date:  2017-11

5.  Sodium-glucose co-transporter (SGLT) inhibitor restores lost axonal varicosities of the myenteric plexus in a mouse model of high-fat diet-induced obesity.

Authors:  Satoshi Shimo; Sei Saitoh; Huy Bang Nguyen; Truc Quynh Thai; Masako Ikutomo; Ken Muramatsu; Nobuhiko Ohno
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

6.  Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats.

Authors:  Kenji Takeda; Hiraku Ono; Ko Ishikawa; Tomohiro Ohno; Jin Kumagai; Hidetoshi Ochiai; Ai Matumoto; Hidetaka Yokoh; Yoshiro Maezawa; Koutaro Yokote
Journal:  BMJ Open Diabetes Res Care       Date:  2021-04

7.  Chronic Effects of a High Sucrose Diet on Murine Gastrointestinal Nutrient Sensor Gene and Protein Expression Levels and Lipid Metabolism.

Authors:  Patrick O'Brien; Ge Han; Priya Ganpathy; Shweta Pitre; Yi Zhang; John Ryan; Pei Ying Sim; Scott V Harding; Robert Gray; Victor R Preedy; Thomas A B Sanders; Christopher P Corpe
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

8.  Functional analysis of a triplet deletion in the gene encoding the sodium glucose transporter 3, a potential risk factor for ADHD.

Authors:  Nadine Schäfer; Maximilian Friedrich; Morten Egevang Jørgensen; Sina Kollert; Hermann Koepsell; Erhard Wischmeyer; Klaus-Peter Lesch; Dietmar Geiger; Frank Döring
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

Review 9.  Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application.

Authors:  Gergely Gyimesi; Jonai Pujol-Giménez; Yoshikatsu Kanai; Matthias A Hediger
Journal:  Pflugers Arch       Date:  2020-08-07       Impact factor: 3.657

10.  Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.

Authors:  Jacob E Pruett; Edgar D Torres Fernandez; Steven J Everman; Ruth M Vinson; Kacey Davenport; Madelyn K Logan; Stephanie A Ye; Damian G Romero; Licy L Yanes Cardozo
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.